Abstract:Background The onset and progression of type 1 diabetes mellitus (T1DM) is closely related to autoimmunity. Effective monitoring of the immune system and developing targeted therapies are frontier fields in T1DM treatment. Currently, the most available tissue that reflects the immune system is peripheral blood mononuclear cells (PBMCs). Thus, the aim of this study was to identify key PBMC biomarkers of T1DM. Methods Common differentially expressed genes (DEGs) were screened from the Gene Expression Omnibus (GEO) datasets GSE9006, GSE72377, and GSE55098, and PBMC mRNA expression in T1DM patients was compared with that in healthy participants by GEO2R. Gene Ontology, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and protein-protein interaction (PPI) network analyses of DEGs were performed using the Cytoscape, DAVID, and STRING databases. The vital hub genes were validated by reverse transcription-polymerase chain reaction using clinical samples. The disease-gene-drug interaction network was built using the Comparative Toxicogenomics Database (CTD) and Drug Gene Interaction Database (DGIdb). Results We found that various biological functions or pathways related to the immune system and glucose metabolism changed in PBMCs from T1DM patients. In the PPI network, the DEGs of module 1 were significantly enriched in processes including inflammatory and immune responses and in pathways of proteoglycans in cancer. Moreover, we focused on four vital hub genes, namely, chitinase-3-like protein 1 (CHI3L1), C-X-C motif chemokine ligand 1 (CXCL1), matrix metallopeptidase 9 (MMP9), and granzyme B (GZMB), and confirmed them in clinical PBMC samples. Furthermore, the disease-gene-drug interaction network revealed the potential of key genes as reference markers in T1DM. Conclusion These results provide new insight into T1DM pathogenesis and novel biomarkers that could be widely representative reference indicators or potential therapeutic targets for clinical applications.

Expression and significance of high-mobility group box 1 in pancreatic tissue of NOD mice

EXPRESSION OF NDRG2 IN PANCREAS,HEART AND KIDNEY OF DIABETIC AND NORMAL MICE

Toll-like Receptor 4 on Islet Β Cells Senses Expression Changes in High-Mobility Group Box 1 and Contributes to the Initiation of Type 1 Diabetes

Specific expression and significance of Toll-like receptor 4 in pancreatic tissue of non-obesediabetic mice

High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications

Research progress in high-mobility group box-1 and diabetic peripheral neuropathy

Expression and significance of the specialized transcription factors within the pancreatic islets of normal and diabetic mice

Study on the Relationship Between High Mobility Group Box 1 and Intestinal Mucosal Barrier Injury in Acute Pancreatitis

The role of high-mobility group box-1 protein in the development of diabetic nephropathy

High mobility group box 1 in diabetic nephropathy

Contribution of Different Mechanisms to Pancreatic Beta-cell Hyper-secretion in Non-obese Diabetic (NOD) Mice During Pre-diabetes

Histopathologic study on pancreatic islets of nonobese diabetic mice orally administrated by insulin

The relationship between HMGB1 and autophagy in the pathogenesis of diabetes and its complications

Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study

Relationship of high mobility group boxl and inflammation

High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV

Pancreatic ductal cell antigens are important in the development of invasive insulitis in Non-Obese Diabetic mice

Changes of Gene Expression Profile in Non-Obese Diabetic Mice during the Development of Type 1 Diabetes Mellitus

Clinical significance of high-mobility group box-1 (HMGB1) in subjects with type 2 diabetes mellitus (T2DM) combined with chronic obstructive pulmonary disease (COPD)

Proteomic analysis of mouse islets after multiple low-dose streptozotocin injection

Identification of Key Genes and Pathways in Peripheral Blood Mononuclear Cells of Type 1 Diabetes Mellitus by Integrated Bioinformatics Analysis